• homepage-lymphoma-slider-3
  • cLBT Golden retriever banner PNG


Lymphoma is one of the most common malignancies to affect dogs, having an estimated annual incidence of approximately 25 per 100,000 dogs. Typical presenting signs include lymphadenopathy, PU/PD, hypercalcaemia and vomiting and diarrhoea

Find out more about canine lymphoma

Performance and clinical application of cLBT

The test measures levels of C-Reactive Protein (C-RP) and Haptoglobin (HAPT) and combines these readings in a unique algorithm, providing a new and valuable tool in the diagnosis of canine lymphoma, particularly in cases of inconclusive or inaccurate FNAs. It is also capable of detecting relapse up to 8 weeks prior to physical symptoms, and therefore assists in the monitoring of lymphoma for both remission status and early detection of disease recurrence.

Read more on our canine lymphoma test and its performance